MENU
SLS
AS OF
Dec 12 closing price
Price
$2.03
Change
+$0.02 (+1.00%)
Capitalization
289.16M
90 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
SLS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

SELLAS Life Sciences Group (SLS) Ownership - Who owns SELLAS Life Sciences Group?

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
7 Times Square
Phone
+1 646 200-5278
Employees
16
Web
https://www.sellaslifesciences.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
289.16M
P/E Ratio
N/A
Total Cash
44.32M
Projected Growth
N/A
Total Debt
599K
Revenue
N/A
Risk (Beta)
1.81
Dividend Yield
N/A
Total Cash/Share
0.31
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

SLS
Capitalization
289M
P/E Ratio
N/A
Risk (Beta)
1.81
Dividend Yield
N/A
Total Cash
44.3M
Total Cash/Share
0.31
Total Debt
599K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
45.6M
P/B Ratio
6.34
Cash Flow
N/A
Earnings
-0.28
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
12K
Current Ratio
8.28
Current Revenue Per Employee
90909.09
Dividends Per Share - Security
N/A
EBITDA
-26.94M
Float
N/A
Float - Current
N/A
Gross Income Margin
90.00
Revenue To Assets
-66.47
Shares Held By Institutions
80.8M
Shares Outstanding - Current
142M
Total Liabilities
5.93M
Total Volume MTD
N/A
Value
N/A
Gain YTD
93.269
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
SLS
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. SLS showed earnings on November 12, 2025. You can read more about the earnings report here.
View AI-Driven Trading for SLS
A.I. Advisor
published General Information

General Information

a developer of biopharmaceuticals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
7 Times Square
Phone
+1 646 200-5278
Employees
16
Web
https://www.sellaslifesciences.com